Nightingale Health

0.87 EUR

-2.25 %

4,700 following

HEALTH

NASDAQ Helsinki

Medical Equipment & Services

Health Care

-2.25 %
-28.69 %
-43.73 %
-57.56 %
-61.59 %
-68.93 %
-12.91 %
-83.63 %
-83.11 %

Nightingale Health operates in the medical technology sector. The company specializes in the development of medical technology products. The product portfolio is broad and includes platforms and services within blood analysis that are used for disease prevention purposes. In addition to the main business, service and related ancillary services are also offered. The business is operated globally with the largest presence in Europe.

Read more
Market cap
53.02M EUR
Turnover
267.09K EUR
P/E (adj.) (26e)
-3.29
EV/EBIT (adj.) (26e)
-0.76
P/B (26e)
1
EV/S (26e)
1.59
Dividend yield-% (26e)
-
Coverage
Recommendation
Accumulate
Target price
1.70 EUR
Updated
05.03.2026
Disclaimer
Antti Luiro
Antti Siltanen
Antti Siltanen, Antti Luiro
Show more
Latest research

Latest analysis report

Released: 06.03.2026

Latest extensive report

Released: 13.06.2025

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Risk
Business risk
Valuation risk
Low
High
ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Forum discussions
Hi, the volume has indeed been heavy. However, I avoid speculating on short-term price movements or daily trading. There are currently too few facts to draw any conclusions. Let’s take another look if there are any flagging notifications or other interesting news.
yesterday
by Antti Siltanen
23
Eloisa Hyvinvointilahja Vuosina 1971, 1976 ja 1981 syntyneet Etelä-Savon asukkaat saavat Eloisalta hyvinvointilahjan. Eloisa etsii yhteistyökumppaneidensa kanssa kyseisten syntymävuosien ikäluokista 1 400 vapaaehtoista…
5/24/2026, 6:55 AM
by Pertti
14
Here are Antti’s comments regarding Nightingale’s new partnership. Nightingale Health announced on Friday that it has signed a Letter of Intent (LoI) with Formula 100 Health to integrate its blood analysis technology into the partner’s longevity programs in Switzerland and South ...
yesterday
by Sijoittaja-alokas
11
30% of the listed share class has now changed hands in six trading days. Hopefully, active owners will replace the passive former ones. Same in image form:
15 hours ago
by Puutaheinää
6
Is Nightingale still under @Antti_Siltanen’s coverage? It would be interesting to hear if the analyst has any thoughts on what’s currently going on​
5/23/2026, 10:34 AM
by NOKNOK
6
Known or unknown, when a third of the ownership changes hands rapidly, it will have a broader impact. Someone is buying, and likely not just to become a new passive owner.
14 hours ago
by Puutaheinää
4
This would then be a scenario where we have an exceptionally good buying opportunity, as the reason for the price slump would be a major owner sweeping away a previously strategic investment that has become redundant, occurring at a time when the price is already low.
5/23/2026, 7:34 AM
by Puutaheinää
3
Read more on our forum

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.